Header Bar
  eNewsLine - Reporting our progress in the battle against leukemia, lymphoma, Hodgkin's disease and myeloma  

 
APRIL 2009
888.HELP.LLS Donate Now Forward to a Friend
 

Debby Cox FEATURED ARTICLE

Research Wins the Game
Austin Supporter Debby Cox Explains READ MORE
Team in Training® Logo

FUNDRAISING UPDATES

"Why They Run" - TNT documentary debuts at Memphis Film Festival this month
READ MORE

Team In Training Is Your Ticket in to the Sold-Out Nation's Tri
READ MORE

Regatta Season is Underway
here are a few great stories of outstanding participants READ MORE

Gary Jobson Nominated President of US Sailing READ MORE

Man & Woman of the Year Sees More "Champions of Hope" Than Ever Before READ MORE

Make a Tribute Donation to LLS in Honor of
Your Mother
READ MORE

Kendall Kollection - Kicking off its Second Year
READ MORE

PATIENT SERVICES

National Capital Area Chapter donates technology to help students
in treatment stay in touch with class/school
  READ MORE

LLS bestows award to outstanding social worker Nancy Boyle 

READ MORE

Upcoming Telephone Education Programs  READ MORE

Featured Resources  READ MORE

RESEARCH

This month, eNewsline introduces the work of Sagar Lonial, M.DREAD MORE

Updates on TAP clinical trials  READ MORE

ADVOCACY

Cancer Clinical Trials Bills Introduced in Congress  READ MORE

ACT NOW! Urge Congress to Co-Sponsor Access to Cancer Clinical Trails Legislation  TAKE ACTION


FROM THE LLS BLOG  READ MORE


Mother's Day Banner
 

News Room Image

PRESS RELEASES

Visit our Web site regularly to read the latest LLS press releases.

RSS Icon NEWS FEEDS & PODCASTS

We are all inventors, each sailing out on a voyage of discovery, guided each by a private chart, of which there is no duplicate. The world is all gates, all opportunities. -Ralph Waldo Emerson

FEATURED ARTICLE

Debby Cox and her husband, Rick CoxResearch Wins the Game
Austin Supporter Debby Cox Explains

Sometimes timing is everything.

"If I had been talking to you a year ago, I would be telling you that you have three to five years to live and that we would be doing a lot of different things to keep you alive," Debby Cox's doctor told her after diagnosing her with chronic myelogenous leukemia (CML) on March 20,2002.  "But today I am happy to tell you that there is a great new drug: Gleevec
®," the doctor continued.

Gleevec is "the magic pill" developed by The Leukemia & Lymphoma Society (LLS) - funded researcher, Brian Druker, M.D., of Oregon Health and Science University Cancer Institute, thanks in large part to hundreds of generous LLS donors whose financial support helped keep his research going. Cox, of Austin, Texas, also feels strongly about the LLS research she and her husband Rick support. They recently made a commitment of $30,000 to support a portfolio of researchers investigating CML at all levels from basic science to therapy.

From her initial diagnosis in 2002 to the decision to make a major gift to research, there were many years of involvement. Following her diagnosis, Cox began to learn everything she could about leukemia. Not surprisingly, everywhere she turned, there was The Leukemia & Lymphoma Society. 

She saw a commercial on TV advertising the Light The Night® Walk and decided to raise money and attend the walk with her husband and her daughter, Amanda. Light The Night Walk is LLS's annual walk held in fall in communities across the country to pay tribute to lives touched by cancer. Participants carry illuminated balloons - white for survivors, red for supporters and gold for those who are walking in memory of a loved one.

"This lady who I had never seen before walked into our office and said I have some money that I raised for last night's walk and I need to give it to you," says Jane Sierra, the former walk director for the Central Texas Chapter of LLS. "Inside the bag was $6,000 that Debby had raised completely on her own." By the next year, she was on the board and co-chairing Family Teams for the Walk.

Although Cox loves Light The Night Walk, for her it is all about the research.
 
"Each year it seems that there are more and more of the white balloons of survivors," she said. "Research is where we win the game." 

She also feels a personal obligation.

"Someone else contributed to create Gleevec and now my husband and I want to be part of the next pill to help the next person. I already know that Gleevec will not work forever for me, so part of it is selfish and part of it is knowing that something good will come of it for others."

Another aspect about LLS that Cox cherishes are the close friendships she has formed with her fellow board members and the staff.

"There is a true sense of stewardship of both human relationships and funds," she says. "I could only give to an organization that I felt was completely genuine and transparent."
 
Elizabeth Muenzler, executive director of the Central Texas Chapter of LLS, describes Cox this way: "She and her husband honestly do not view themselves as 'philanthropists,' but rather small cogs in a big wheel where everyone contributes to make the world a better place. She is a humble, fun-loving person who feels blessed to be able to give when in fact we are the ones who are lucky to have her." 

Cox sums it up more simply: "It's our version of 'paying it forward.'"

Back to the top

FUNDRAISING UPDATES

Team in Training® Logo

Why They Run

Five Chicago metro area residents with very different but equally compelling personal stories are featured in a documentary film
"Why They Run" that made its world premiere at
On Location: Memphis, the Memphis International Film Festival

this month. The one thing that all five had in common was the goal of completing the Chicago Marathon and raising money to support The Leukemia & Lymphoma Society's (LLS) initiatives to fund research for leukemia, lymphoma and myeloma. All signed on as members of LLS's Team In Training.

 The film follows the five as they take on the daunting challenge of preparing for the marathon, despite physical and emotional setbacks - they are older, out of shape and overwhelmed by life's curveballs. The cast: Lesley Spencer, 55, also the film's producer, is a gifted composer; Marty Yundt, 53, a SWAT police sergeant from Lake Zurich, Illinois, and recovering from a divorce; Mimi Noonan, 44, a mother whose son, Keegan, was battling leukemia; Vanessa de Ingardia, 38, a lymphoma survivor; Ron Williams, 70, a retired marketing consultant who has completed 31 Chicago Marathons!

"I used to think there was nothing I could do to make a difference in the world," says Spencer. "But since I joined TNT and started meeting the people we're helping, I've learned that nothing could be further from the truth. I've learned that even a small thing can make a really big difference in the life of a cancer patient."

Directed by Olga Arango. The film will be available for viewing online in May at
www.whytheyrun.com


Back to the top



Leukemia Cup Regtta LogoRegatta Season is Underway

It's all hands on deck for the 2009 Leukemia Cup Regatta season, which is well under way, and across the country sailors' commitment to the mission is as strong as ever.

In New Orleans, Chuck Stuckey, 25, participates in the program in a slightly unconventional way. On March 22, he kiteboarded across Lake Ponchartrain to honor his father, who died from acute myelogenous leukemia. He raised $12,000 to support The Leukemia & Lymphoma Society's blood cancer research and patient services initiatives.

Grace Palmer, 16, of Savannah, Georgia, sails to honor her grandfathers, both of whom have multiple myeloma. Over the four years she has been participating in the Leukemia Cup Regatta she has raised $29,000. The Savannah Yacht Club will hold its Leukemia Cup Regatta the weekend of September 19-21.

"I plan to participate in LCR for as long as I am able to," says Palmer. "My knowledge about sailing is something I will always have and be able to use. It isn't like other sports that you can only be good at for a certain amount of time until you get too old. Sailing in the Leukemia Cup Regatta has been one of the best experiences of my life. I think it is very important to raise money for a cause. As a young person, fundraising is one of the most effective ways that I can help find a cure for these diseases."
 
Monroe, Washington police officer Ken Sahlstrom, 57, sails in memory of his son, Jonathan, who lost his battle to leukemia in 2006 at the age of 17. He also sails to honor his nephew, Noah, recently diagnosed with cancer. Sahlstrom is joined by two fellow officers, Reid Weaver, who lost his son Jackson to leukemia in 2006, and Rick Dunn, whose son Callahan, is a leukemia survivor. Both Callahan and Noah will join the men in this year's sail. The Elliott Bay Marina in Seattle will hold its Regatta on June 6. In the four years that Sahlstrom and his fellow police officers have participated in the Regatta they have raised more than $11,000 to help fund lifesaving research.

Lisa Thorndike, 68, of southern New Jersey, was diagnosed in 1993 with solitary plasmacytoma which progressed to multiple myeloma. She had two stem cell transplants in 1997 and was in remission for 10 years. No longer in remission, Thorndike is either going to participate in a clinical trial or have a third stem cell transplant. Despite her battles with the disease, Thorndike has been undaunted in her dedication to the Leukemia Cup Regatta. Her regatta fundraising has resulted in $230,000 to help find a cure! Thorndike is eligible for her 11th Fantasy Sail, taking place in October in San Francisco. She will participate in her 14th Leukemia Cup Regatta the weekend of June 13 and 14 at the Keyport Yacht Club in New Jersey.

For more information about the 2009 Regatta series, please call 888.HELP.LLS or visit
www.leukemiacup.org.


Back to the top


Gary JobsonLeukemia Cup Regatta Chairman Gary Jobson in Line for US Sailing Post

US Sailing, the national governing body of the sport, announced last month at the group's spring meeting in Denver that the Nominating and Governance Committee intends to nominate Gary Jobson of Annapolis, Md., as the organization's next president. The position of president will be elected by the board of directors at US Sailing's Annual General Meeting in Houston Oct. 25, 2009. "US Sailing is a vital component of our sport," said Jobson. "At this time in my life, I look forward to serving the sport that has been so good to me for so many years." Jobson is the national chairman of The Leukemia & Lymphoma Society's Leukemia Cup Regatta, which has generated over $28 million to support blood cancer research and patient services.


Back to the top


Man and Woman of the Year LogoChampions of Hope

With over 500 candidates, LLS's Man & Woman of the Year Campaign has more "champions of hope" than ever in the history of the program.

During a ten-week fundraising period beginning with a kickoff celebration, the candidates are judged solely on their success in raising money to help LLS fund research to find cures and better therapies, and provide information and support to blood cancer patients and their families. The local Man & Woman of the Year are the top fundraisers in their community. The national title is awarded to the top fundraisers in the country, to be announced early this summer.

Every dollar raised counts as one "vote." The candidates compete in honor of LLS's Boy & Girl of the Year, local children who are blood cancer survivors and sources of inspiration to others. 

"The select group of 2009 Man & Woman candidates are carrying on the tradition of using their passion and determination to raise funds that give thousands of people battling blood cancers the chance to live better, longer lives," said Blair Fogle, the national manager of the program. "Each year is even more thrilling. This is a campaign that celebrates not only the individual accomplishments, but the collective success of all these amazing candidates." 

To learn more about this year's candidates, and the campaign, visit
www.manwomanoftheyear.org.


Back to the top


This Mother's Day Celebrate a Mother's Love
Honor Your Mother with a Tribute Gift to The Leukemia & Lymphoma Society

Mom and Daughter image

For all the acts of kindness, large and small, that mothers perform on behalf of their children and other loved ones every day, now is the perfect time to do something special to pay tribute to mothers.

Consider the heroic gesture performed by Katy Moeller of Santa Monica, Calif. There is nothing more terrifying for a mother than to watch helplessly as her child suffers. Moeller watched in agony as her three-year-old daughter, Audrey, battled leukemia several years ago. To honor her daughter's battle, Moeller took on a physical challenge of her own. She signed on with The Leukemia & Lymphoma Society's Team In Training and ran in the Carlsbad Marathon in January 2008 while raising funds to support live-saving blood cancer research, education and patient services. Now five, Audrey has responded well to treatment and living a fairly normal life for a child her age.

"TNT enabled me to do something positive for Audrey and all others fighting blood cancers," Moeller says.

Moeller's act is a powerful example of a mother's love. Now you can do something special to show appreciation for all the ways that mothers such as Moeller do for others. You can pay homage to your own mother by going to
www.lls.org/donate and making a donation, helping to ensure that every child stricken with a blood cancer can live a long and prosperous life. You can designate your gift in honor of your mother and a special card will be sent to her attention.

In order to have the acknowledgement card sent by Mother's Day your tribute donation must be made by May 4!


Back to the top


Kendall Kollection LogoKendall Kollection - Kicking off its Second Year

When Jacqueline Savage McFee, a designer of popular trendy school and office fashion products, got the devastating news that her two-year-old cousin, Kendall Sierens, was diagnosed with leukemia, it brought things into perspective for her. It also created a spark. The Kendall Kollection - a collection of colorful high-end school supplies inspired by the artist's young cousin - was born in 2008 and has been raising funds and awareness for The Leukemia & Lymphoma Society (LLS).   Now LLS has announced it will be partnering with McFee again this year in the hopes of raising even more money to fight blood cancer.

The new Kendall Kollection, including notebooks, journals, laptop bags, pens, pencils, folders will be featured in major retailers across the country including Wal-Mart, Office Max, Staples, and Kmart, beginning in May, 2009.

"Jackie's dynamic designs have been drawing attention for several years now," says Nancy L. Klein, LLS's chief marketing and revenue officer. "LLS is so grateful to Jackie and CP for recognizing the incredible impact that using her talent to help raise awareness and funds can have in the effort to find cures and better therapies for patients with leukemia, lymphoma and myeloma."

"Kendall is now five-and-a-half and in remission, and to know I could help to make a positive difference in her life and her family by supporting LLS means the world to me," says McFee. To learn more visit
www.jackiemcfee.com.



Back to the top


PATIENT SERVICES

Presenting laptop to the hospital staffNational Capital Area Chapter Donates Webcams Enabling Hospitalized Children to Connect with Classrooms, Teachers and Friends

This year, when six year-old Becky Wilson of Arlington was about half way through first grade and her leukemia was in remission, her immune cell count dropped to a low level. It became too risky for her to attend school or be with friends at Jamestown Elementary School in Arlington.

But thanks to a new program at Georgetown made possible by The Leukemia & Lymphoma Society's National Capital Area (NCA) Chapter, Becky was able to stay in contact with her teacher and classmates until she is able to return to school via a new project at Georgetown University Hospital that uses laptops and webcams to link kids from the hospital to their classrooms, teachers and friends. For example, during one session, Becky was able to talk to her classmates about recent assignments in reading, and participate in discussions about how the Great Wall of China was built and weather disasters like tornadoes. Becky followed along and took some notes. The children let her know they made her a box of Valentines.

The NCA Chapter conceived of the idea and donated six laptops with built-in webcams for the children at Georgetown and six webcams for parents to take to their child's school for classroom setup. This program is a first for the local LLS chapter. The gift of the equipment was made possible by the generous donors who attended the 2008 Bobby Mitchell TOYOTA Hall of Fame Golf Classic last summer. The event is led by co-chairs Tammy Darvish of DARCARS, Todd Heavner of Enterprise rent-a-car and Bobby Mitchell.

"The National Capital Area Chapter of The Leukemia & Lymphoma Society is thrilled to be able to donate these webcams to the children at Georgetown's Lombardi Cancer Center," says Donna McKelvey, Executive Director of the chapter. "We are so grateful to our donors from The Bobby Mitchell TOYOTA Hall of Fame Golf Classic for making this technology available so that children who are taken out of school due to cancer treatment can truly feel like they are, once again, connected to their classroom so that they can continue their education alongside their classmates."

Becky Wilson at laptop Pediatric Hematology/Oncology director Aziza Shad, M.D. said, "Having this technology available is really a turning point for children with cancer and other serious illnesses. When some of our children are newly diagnosed with leukemia they need to be out of school for one to three years because they are immune compromised from their chemotherapy. They miss their teachers. They miss their friends. These laptops with webcams provide a perfect way for them to participate in a lesson and stay connected with their school. We are very grateful to The Leukemia & Lymphoma Society for donating the equipment to make this possible."

Mary Lane, L.I.C.S.W., clinical social worker who helps children navigate school and educational issues once they start cancer treatment at Georgetown said it is psychologically good for children to keep in contact with their teachers and friends.

"They can continue to feel connected even if they're not there. Their school and their friends are often a very positive part of their life and it's important to maintain those positive connections."

To learn more about pediatric blood cancers, please visit:
Other ways patients stay connected:

Back to the top


Nancy J. Boyle, M.S.W., L.C.S.W.
LLS Bestows First Annual Award to Oncology Social Worker
from Oregon


The Leukemia & Lymphoma Society is recognizing the outstanding career of Nancy J. Boyle, M.S.W., L.C.S.W., of Oregon Health & Sciences University (OHSU), with the first LLS Hematology-Oncology Social Worker of the Year Award. The award will be presented on May 7 at the annual Association of Oncology Social Workers conference in Savannah, GA.

In her 23-year career, the past 16 spent at OHSU, Boyle has played an instrumental role in supporting the psychosocial needs of both pediatric and adult blood cancer patients requiring bone marrow and stem cell transplantation. She is sought out for her expertise on the topic throughout the state and across the country.

Among the achievements for which she is being recognized is the implementation of mandatory psychosocial screening by a social worker for stem cell and bone marrow transplant patients. Boyle developed a multi disciplinary working committee and within six months was overseeing a program that was successfully transitioning patients through the palliative care process.

Boyle has partnered with LLS on numerous educational and patient support programs, and regularly coordinates with LLS on patient financial needs, helping to create a seamless process to get patients the assistance they need for transportation and housing. She has played an invaluable role in helping underinsured patients find unrelated donors for life-saving stem cell transplants.

"There were many candidates for this award and each one of them was so qualified and dedicated to the patients they serve," said Hildy Dillon, senior vice president of patient services for LLS. "Nancy's work has been exemplary over her entire career and we received many glowing letters of recommendation submitted on her behalf. This award is testimony to how important social workers are in supporting patients when they are faced with a devastating diagnosis. This is why LLS is recognizing the critical work that social workers like Nancy Boyle perform every day."

The colleagues who submitted letters on her behalf also unanimously agreed that she not only has established herself as an exceedingly accomplished clinician, but as a leader among social workers at OHSU, and across the state and country. Nancy is valued by her colleagues and patients for her wisdom, insights and sensitivity, and many noted that she tirelessly approaches her job with grace, humor and compassion.

"I am overwhelmed by this honor," said Boyle. "I know that I have a great deal of wonderful colleagues who would also be perfect candidates for this award. I am grateful for the recognition and realize that it is not lightly bestowed. I hope that I can continue to reflect the values of AOSW and LLS, two organizations that have been instrumental in my development as an oncology social worker."

Back to the top


Upcoming Telephone Education ProgramsWoman on Phone
(all programs are free)

What: Myeloma: Understanding Drug Therapy and Stem Cell Transplantation
When: Thursday, May 14, noon - 1:30 p.m. ET
Guest Speaker: Seema Singhal, M.D., Division of Hematology/Oncology, Northwestern University

Register online

What: CML: Understanding Treatment, Monitoring Response
When: Tuesday, May 19, noon - 1 p.m. ET
Guest Speaker: Eric J. Feldman, M.D., New York-Presbyterian Hospital/Weill Cornell Medical College

Register online


What: Childhood Cancer Survivorship: Challenges, Strategies, Resources
When: Tuesday May 26, noon - 1:30 p.m.
Guest Speaker: Daniel Armstrong, Ph.D, University of Miami Miller School of Medicine, Pediatrics, and Nancy F. Cincotta, M.S.W., .L.C.S.W., A.C.S.W., B.C.D.,Psychosocial Director, Camp Sunshine, Casco, Maine.

Register online

Back to the top


Featured Resources

Copay ImageFunds are available now!

Is it difficult or impossible for you to afford medicine co-pays or your health insurance premiums?

Funds are available for approved patients with chronic myelogenous leukemia (CML) who have a household income at or below 500% above the US federal poverty guidelines. LLS is changing lives by extending a helping hand when patients need it the most.

Just ask Joe, a recent Co-Pay Assistance Program recipient who has Medicare Part D prescription coverage. "Without the help I have received from LLS, I wouldn't have been able to afford my lifesaving medicine," says Joe. Julie, another patient with CML who has benefited from the program, says, "My husband has been laid off from his job.  The money has helped so much, especially now with the economy the way it is. So my advice to others is to check out the program and apply!"

For more information, call 877-LLS-COPAY (877-557-2672).

You can also go online to www.LLS.org/copay, or send an e-mail to copay@LLS.org.

Back to the top


NEW National Education Series Web PagesKeyboard

Announcing the launch of our NEW National Education Series pages for lymphoma, leukemia, myeloma, MDS and survivorship on our website. These new pages add a fresh new look and will be easier to navigate for the user. We welcome you to browse around these new easier friendly pages.

Back to the top


Web ImageNew Section of Website

We have added a new section to our Childhood Blood Cancers page on juvenile myelomonocytic leukemia, which includes basic information about the disease and links to the JMML page and the Chronic myelomonocytic leukemia and Juvenile myelomonocytic leukemia fact sheet.
 
The updated page is live now. We invite you to take a look at your first opportunity.

Back to the top



Featured Publications

Myeloma Publications

Myeloma Publications


CML Publications  











Treatment Related Publications













Back to the top


From the LLS Blog

We're pleased to highlight a new LLS blog post from our Web site, www.LLS.org, every issue. This month:

Introducing the LLS Blood Cancer Discussion Boards!

Does your child have cancer? Find out about our many resources for parents

Get Into the Nike Women's Marathon with Team In Training

Back to the top

RESEARCH
Sagar Lonial, M.D.
Sagar Lonial, M.D. is associate professor, hematology/medical oncology at Emory University in Atlanta. Dr. Lonial, a recipient of a Translational Research Program grant from LLS, is studying a combination therapy for patients with myeloma and other blood cancers.

What is the biomedical problem/issue that you are trying to resolve? 
The proteasome is a piece of cellular machinery that removes unnecessary proteins from cells. But in some blood cancers, such as myeloma, the proteasome may function abnormally. The targeted drug Velcade (bortezomib) works for many myeloma patients by inhibiting the proteasome. But myeloma and other cancer cells can resist being killed by Velcade. Our group is trying to better understand how cancer cells become resistant and if we can overcome that resistance, especially by making Velcade more effective in combination with other drugs. 

What's novel or innovative about your approach?
Our approach is novel because we are trying to choose drug combinations based upon preclinical evidence gathered in our laboratory studies, rather than just randomly combining available drugs. Our preliminary findings suggest that we can really improve the efficacy of Velcade for patients with myeloma by combining it with Zarnestra (tipifarnib), an experimental drug that has been shown to inhibit an enzyme that can cause excessive growth of cancer cells. Zarnestra really does not kill many myeloma cells when used alone, but the anti-myeloma effect of the combination is quite striking in laboratory tests. 

How will your work one day help patients?
We are currently enrolling patients in an early phase clinical trial based upon our laboratory data, and have seen responses among patients with myeloma who were resistant to Velcade as a single agent. We are now testing higher dose levels and hope to show that the combination is measurably more effective in patients than Velcade alone, as is true in laboratory tests.

Are you close to clinical trials?
The trial is open; 23 patients have been enrolled so far.
 
What other projects are you excited about and believe will benefit patients?
I think the excitement is around the addition of these new agents in treatments for patients with newly diagnosed disease where combinations might be able to result in complete remissions, and possibly even durable complete remissions. In the setting of relapsed disease, new combinations may allow us to treat patients with lower doses of each respective agent to reduce side effects, or use standard dosing but with improved outcomes as measured by number and duration of responses.

What are some of your hobbies and non-research interests?
My hobbies are golf and wine tasting, only one of which I enjoy doing with my kids. I also enjoy traveling, which I am able to do a bit through the myeloma community. 

Back to the top



Aaron D. Schimmer, F.R.C.P.C., M.D., Ph.D. TAP Advancing Clinical Trials

The LLS Therapy Acceleration Program's Academic Concierge Division continues to successfully leverage LLS research investments by helping select LLS-funded academic investigators move new therapies toward market approval. On April 22, 2009, LLS will present one of its Academic Concierge projects, headed by Principal Investigator Aaron D. Schimmer, F.R.C.P.C., M.D., Ph.D., Ontario Cancer Institute (shown here), at a meeting with Health Canada (the Canadian equivalent of the U.S. Food and Drug Administration) and discuss next steps toward opening a Phase I clinical trial.  Barring any concerns from Health Canada, the program is on track to open LLS's first AC Division clinical trial in the fall of 2009.

In conjunction with the LLS National Board of Directors meeting held March 13th in Newark, N.J., the Therapy Acceleration Program Governance Committee reviewed the progress of the Cleveland Clinic partnership in the Clinical Trials Program Division and approved a third LLS-supported trial to open at the Clinical Trial Center for Hematologic Malignancies.  This Phase I/II trial will combine two approved therapies, Lenalidomide and Rituximab, for maintenance therapy following high-dose chemotherapy and autologous stem cell transplantation in patients with B-cell non-Hodgkin's lymphoma.

Also exciting is news that the Cleveland Clinic will utilize three of its community treatment centers when it becomes a trial site for LLS's partner, Aegera Therapeutics, and the ongoing
Phase I/II trial of a new drug (AEG35156) . The Cleveland Clinic's main campus and three regional hospital centers will begin recruiting patients with relapsed or refractory chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma or follicular lymphoma for treatment with Aegera's AEG35156, that inhibits a molecule called X-Linked Inhibitor of Apoptosis (XIAP). This is a significant step toward LLS's goal of enhancing access to clinical trials by "taking the trial to the patient."

In order to leverage its successful clinical trial partnership with the Cleveland Clinic and to further address issues that currently limit clinical trial participation, LLS hosted a 1 1/2 day workshop this past February in San Francisco. Ron Levy, M.D., professor and chief, Division of Oncology at Stanford University, led discussions in which clinical trials experts reviewed ongoing models for early phase blood cancer treatment trials, including roles for-profit companies and government agencies can play, and considered how LLS can best use its resources to help increase participation in practice-changing trials. Workshop discussions provided many insights that will enable future partnerships for the LLS Clinical Trials Program.


Back to the top

ADVOCACY
Cancer Clinical Trials Bills Introduced in Congress Capitol Image

We all know that clinical trials are the roadmap to cures for blood cancers. However, only 3 to 5 percent of adult cancer patients enroll in a clinical trial. The denial by insurers of "routine care costs," such as blood tests, doctor visits and radiological services, can prevent patients from exploring the option of participating in these cutting-edge treatments due to the fear of paying for procedures out-of-pocket.

Increasing patient access to cancer clinical trials is a primary focus of LLS's legislative activities. This goal was laid out in LLS's latest Strategic Plan and much of the movement has centered on state-based advocacy campaigns. To date, 24 states and the District of Columbia have either passed laws or consensus agreements requiring private insurers to cover routine care costs for patients enrolling in a clinical trial. But these bills only affect cancer patients covered by state-based healthcare plans, leaving about 50 percent of the American workforce unaffected.

To address this problem, Sen. Sherrod Brown (D-OH) introduced the Cancer C
linical Trials Act ( S 488) on February 26. The bill would prevent healthcare plans - both ERISA and state-regulated - from denying patients enrolled in clinical trials services that would have been covered under their plan had they participated in what is considered standard therapy. Companion legislation ( HR 716) has been introduced in the U.S. House of Representatives by Rep. Steve Israel (D-NY).

LLS supports any legislative initiative to increase patient access to clinical trials.  However, the legislation introduced by Brown and Israel are the most comprehensive bills addressing the problem, to date, and would protect all Americans with health coverage.

ACT NOW! Urge Congress to Co-Sponsor Access to Cancer Clinical Trails Legislation TAKE ACTION

Back to the top


You are currently receiving national news from LLS.  Your local chapter may also produce a local eNewsletter called The Chapter Report.  If you'd like to receive The Chapter Report please contact your local chapter to subscribe. 

Click here to find your chapter's contact information. 

  Supported by an unrestricted educational grant from Cephalon Oncology Allos Therapeutics, Inc

eNEWSLINE is published by The Leukemia & Lymphoma Society®
Home Office  1311 Mamaroneck Avenue White Plains, NY 10605
914.949.5213
www.LLS.org

© 2009 The Leukemia & Lymphoma Society
All Rights Reserved

The Leukemia & Lymphoma Society Logo

Donate Now

Participating member of An Alliance of America's Premier Health Charities in the Combined Federal Campaign, the National Coalition for Cancer Research and Blood Cancer Coalition. This publication is designed to provide information in regard to the subject matter covered, and is distributed as a public service by The Leukemia & Lymphoma Society, with the understanding that LLS is not engaged in rendering medical or other professional services.

The Leukemia & Lymphoma Society® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services.

Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org or contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET.
www.lls.org.

Visit our e-Store & Special Offers page, where you can support businesses that support LLS.

Please remember LLS in your will or as a beneficiary in your retirement plan. For information, call (888) 773-9958.